Natural product-based anticancer therapy: Ursolic acid increases the expression of tumor suppressor BTG2 via down regulation of its target gene, 2/March/2015, 13.04

Molecular therapy for Human Cancer: Roquin [RING finger and CCCH-type zinc finger domain-containing protein 1] suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 2/March/2015, 12.57 pm
March 2, 2015
Natural product-based therapy for Melonama: Diallyl trisulfide, a compound isolated from Garlic, increases the expression of ADAR1 and inhibits melanoma progression via down regulation of its target gene, 2/March/2015, 13.10
March 2, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Natural product-based anticancer therapy: Ursolic acid increases  the expression of tumor suppressor BTG2 via down regulation of its target gene, 2/March/2015, 13.04, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Ursolic acid, by decreasing the expression of its target gene, it may increase the expression of BTG2. Thereby, it may inhibit cancer progression. Thus, pharmacological formulations encompassing “Ursolic acid or its analogues”  can be used to inhibit the progression of human tumors

Amount: $ 300

Undisclosed information: How Ursolic acid increases the expression of BTG2

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.